We are live on ! Find out more
NFC

Northeast Financial Consultants Portfolio holdings

AUM $2.45B
1-Year Est. Return 15.14%
This Fund
S&P 500
This Quarter Est. Return
+10.24%
1 Year Est. Return
+15.14%
3 Year Est. Return
+63.77%
5 Year Est. Return
+108.46%
10 Year Est. Return
+198.58%
AUM
$1.66B
AUM Growth
+$159M
Cap. Flow
+$24.1M
Cap. Flow %
1.45%
Top 10 Hldgs %
48.61%
Holding
380
New
28
Increased
87
Reduced
94
Closed
24

Sector Composition

Rank Sector Weight
1 Healthcare 10.47%
2 Technology 9.17%
3 Financials 8.76%
4 Communication Services 5.44%
5 Consumer Discretionary 4.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KHC icon
326
Kraft Heinz
KHC
$29B
$222K 0.01%
6,192
DEO icon
327
Diageo
DEO
$51.9B
$220K 0.01%
+1,000
New +$205K
OGN icon
328
Organon & Co
OGN
$3.59B
$218K 0.01%
7,146
-1,444
-17% -$47K
TLT icon
329
iShares 20+ Year Treasury Bond ETF
TLT
$40.6B
$218K 0.01%
1,473
CARR icon
330
Carrier Global
CARR
$52.2B
$212K 0.01%
3,901
CL icon
331
Colgate-Palmolive
CL
$73.9B
$211K 0.01%
+2,476
New +$193K
SLB icon
332
SLB Ltd
SLB
$78.5B
$208K 0.01%
6,961
-3,375
-33% -$106K
VIOG icon
333
Vanguard S&P Small-Cap 600 Growth ETF
VIOG
$1.13B
$208K 0.01%
+1,740
New +$204K
KMI icon
334
Kinder Morgan
KMI
$70.7B
$206K 0.01%
12,960
WCN
335
Waste Connections
WCN
$42B
$204K 0.01%
+1,500
New +$199K
OKTA icon
336
Okta
OKTA
$25.8B
$202K 0.01%
900
-75
-8% -$17.9K
BDX icon
337
Becton Dickinson
BDX
$49.6B
$201K 0.01%
+820
New +$196K
NAD icon
338
Nuveen Quality Municipal Income Fund
NAD
$2.75B
$177K 0.01%
10,959
CMRX
339
DELISTED
Chimerix, Inc.
CMRX
$166K 0.01%
25,802
MGNX icon
340
MacroGenics
MGNX
$254M
$161K 0.01%
10,000
FTI icon
341
TechnipFMC
FTI
$29.8B
$157K 0.01%
26,600
KG
342
Kestrel Group
KG
$68.3M
$152K 0.01%
2,476
CLSD
343
DELISTED
Clearside Biomedical
CLSD
$146K 0.01%
3,533
+2,666
+307% +$173K
MYN icon
344
BlackRock MuniYield New York Quality Fund
MYN
$377M
$141K 0.01%
10,000
KNSA icon
345
Kiniksa Pharmaceuticals
KNSA
$6.04B
$135K 0.01%
11,440
AUTL
346
Autolus Therapeutics
AUTL
$567M
$115K 0.01%
22,215
LRMR icon
347
Larimar Therapeutics
LRMR
$450M
$109K 0.01%
10,105
ATAXZ
348
DELISTED
AMERICA FIRST TAX EXEMT INV LP
ATAXZ
$103K 0.01%
16,000
PHAS
349
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
$99K 0.01%
+37,760
New +$114K
OCUL icon
350
Ocular Therapeutix
OCUL
$2.26B
$98K 0.01%
14,015

Similar funds

Northeast Financial Consultants's Q4 2021 Portfolio in Review

As of Q4 2021, Northeast Financial Consultants held 380 positions worth $1.66B, up 11% from $1.5B the previous quarter. Its ten largest holdings account for 49% of the portfolio.

Northeast Financial Consultants's Q4 2021 filing shows 28 new, 87 increased, 94 reduced and 24 closed positions. Its largest new stake was State Street SPDR S&P Regional Banking ETF: 18,830 shares worth $1.33M. The largest sale was Broadmark Realty Capital Inc. Common Stock, an estimated $9.65M.

By sector, the portfolio is most concentrated in Healthcare at 10% of assets, up from 9.4% a quarter earlier, followed by Technology and Financials.

  • Northeast Financial Consultants's largest Q4 2021 buy was State Street SPDR S&P Regional Banking ETF: 18,830 shares worth $1.33M.
  • Northeast Financial Consultants added most to State Street SPDR S&P 500 ETF Trust in Q4 2021, an estimated $9.26M increase.
  • Northeast Financial Consultants's biggest Q4 2021 reduction was Broadmark Realty Capital Inc. Common Stock, cutting an estimated $9.65M.
  • Northeast Financial Consultants fully exited Cactus in Q4 2021, selling an estimated $5.51M.
  • Northeast Financial Consultants's ten largest holdings make up 49% of its $1.66B portfolio in Q4 2021.
  • Northeast Financial Consultants opened 28 new positions and closed 24 in Q4 2021.
  • Northeast Financial Consultants's portfolio value rose 11% quarter-over-quarter to $1.66B.

Based on Northeast Financial Consultants's 13F filing for Q4 2021, filed 11 Feb 2022.